Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

Expanded access is no longer available for this treatment.
Sponsor:
Information provided by:
Bayer
ClinicalTrials.gov Identifier:
NCT01646593
First received: July 18, 2012
Last updated: December 12, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is no longer available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given